You are here

HyQvia

Takeda Gets FDA Label Expansion for HyQvia in Rare Autoimmune Disorder

BioSpace

Wed, 01/17/24 - 08:27 pm

demyelinating polyneuropathy

Baxter prepping for HyQvia launch with spinoff's success on the line

Fierce Pharma

Mon, 10/20/14 - 11:36 am

Baxter International

primary immunodeficiency

Baxter and Halozyme sway the FDA after a painful rejection

Fierce Biotech

Mon, 09/15/14 - 11:46 am

Baxter International

FDA panel: Benefit of Baxter's immune therapy outweighs risk

Yahoo/Reuters

Thu, 07/31/14 - 04:03 pm

advisory panels

Baxter International

U.S. FDA panel reviews Baxter immune therapy's long-term safety

Yahoo/Reuters

Wed, 07/30/14 - 06:10 pm

Baxter International

Baxter provides U.S. regulatory update on HyQvia

The Fly on the Wall

Wed, 05/21/14 - 10:13 am

Baxter International

primary immunodeficiency

Baxter submits amended BLA to U.S. FDA for HyQvia

The Fly on the Wall

Mon, 12/2/13 - 10:13 am

Baxter International

Halozyme Rallies On Success In Europe, US Next Target

Seeking Alpha

Tue, 03/26/13 - 10:38 am

Baxter International

Biogen, Baxter, Sanofi, Gilead Win EU Endorsements

Investors.com

Fri, 03/22/13 - 11:45 am

Baxter International